These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 8722503)
21. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities. Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234 [TBL] [Abstract][Full Text] [Related]
22. Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Yu SM; Hsu SY; Ko FN; Chen CC; Huang YL; Huang TF; Teng CM Br J Pharmacol; 1992 Aug; 106(4):797-801. PubMed ID: 1356567 [TBL] [Abstract][Full Text] [Related]
23. Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 2. Hypotensive effects in normotensive and hypertensive rats. Kawakami M; Matsumura S; Shimamura T; Iwasaki T; Furukawa H; Matsunaga K; Yonetani Y; Iwaki K J Cardiovasc Pharmacol; 1996 Nov; 28(5):695-702. PubMed ID: 8945684 [TBL] [Abstract][Full Text] [Related]
24. Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin. Downing OA; Wilson KA; Wilson VG Br J Pharmacol; 1983 Oct; 80(2):315-22. PubMed ID: 6140057 [TBL] [Abstract][Full Text] [Related]
26. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization. Delpy E; le Monnier de Gouville AC Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060 [TBL] [Abstract][Full Text] [Related]
27. (-)-Discretamine, a selective alpha 1D-adrenoceptor antagonist, isolated from Fissistigma glaucescens. Ko FN; Guh JH; Yu SM; Hou YS; Wu YC; Teng CM Br J Pharmacol; 1994 Aug; 112(4):1174-80. PubMed ID: 7952879 [TBL] [Abstract][Full Text] [Related]
28. Mediation of noradrenaline-induced contractions of rat aorta by the alpha 1B-adrenoceptor subtype. Testa R; Guarneri L; Poggesi E; Simonazzi I; Taddei C; Leonardi A Br J Pharmacol; 1995 Feb; 114(4):745-50. PubMed ID: 7773533 [TBL] [Abstract][Full Text] [Related]
29. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist. Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420 [TBL] [Abstract][Full Text] [Related]
30. Antihypertensive and Hypolipidemic Effects of DC-015, a Novel, Potent and Specific alpha(1)-Adrenoceptor Antagonist: Comparison with Prazosin in Spontaneously Hypertensive Rats. Peng IH; Sheu JR; Chern JW; Lee YM; Yen MH J Biomed Sci; 1996 Apr; 3(2):108-116. PubMed ID: 11725091 [TBL] [Abstract][Full Text] [Related]
31. Potent alpha-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments. Shibata S; Satake N; Suh TK; Ishida Y; Ueda S; Follmer C; Flores F Gen Pharmacol; 1986; 17(2):143-9. PubMed ID: 2870954 [TBL] [Abstract][Full Text] [Related]
32. Captopril therapy decreases both expression and function of alpha-adrenoceptors in pre- hypertensive rat aorta. Godínez-Hernández D; Gallardo-Ortíz IA; López-Sánchez P; Villalobos-Molina R Auton Autacoid Pharmacol; 2006 Jan; 26(1):21-9. PubMed ID: 16371063 [TBL] [Abstract][Full Text] [Related]
33. Comparison of cardiovascular effects of SGB-1534 and prazosin, selective alpha 1-adrenoceptor antagonists, in anesthetized dogs. Imagawa J; Nabata H; Sakai K Jpn J Pharmacol; 1987 May; 44(1):35-41. PubMed ID: 2887683 [TBL] [Abstract][Full Text] [Related]
34. Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil. Sugimoto T; Hosoki K; Karasawa T J Cardiovasc Pharmacol; 1995 Jul; 26(1):55-60. PubMed ID: 7564365 [TBL] [Abstract][Full Text] [Related]
35. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin. Haruta K; Baba A; Akima M; Koga T; Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1989; 299():169-84. PubMed ID: 2570554 [TBL] [Abstract][Full Text] [Related]
36. Effect of calcium entry blockers on blood pressure and vasoconstrictor responses to alpha-1 adrenoceptor stimulation in conscious spontaneously hypertensive rats. Thoolen MJ; Miller CR; Chiu AT; Timmermans PB Cardiovasc Drugs Ther; 1987 Dec; 1(4):377-83. PubMed ID: 2908713 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of two distinct alpha 1-adrenoceptor subtypes in rabbit thoracic aorta. Oshita M; Kigoshi S; Muramatsu I Br J Pharmacol; 1993 Apr; 108(4):1071-6. PubMed ID: 8097950 [TBL] [Abstract][Full Text] [Related]
38. Studies on quinazolines. 5. 2,3-dihydroimidazo[1,2-c]quinazoline derivatives: a novel class of potent and selective alpha 1-adrenoceptor antagonists and antihypertensive agents. Chern JW; Tao PL; Yen MH; Lu GY; Shiau CY; Lai YJ; Chien SL; Chan CH J Med Chem; 1993 Jul; 36(15):2196-207. PubMed ID: 8101878 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms of vasorelaxation induced by N-allylsecoboldine in rat thoracic aorta. Yu SM; Lee SS; Hou YS; Teng CM Naunyn Schmiedebergs Arch Pharmacol; 1994 Jun; 349(6):637-43. PubMed ID: 7969515 [TBL] [Abstract][Full Text] [Related]
40. Alpha 1-adrenoceptor antagonist activity of novel pyrimidine derivatives (SHI437 and IK29) in rabbit aorta and trigone of the bladder. Azuma H; Sugimoto-Tokushima M; Tanaka K; Ikenoue Y; Ito S; Ishikawa M Br J Pharmacol; 1989 Apr; 96(4):1000-6. PubMed ID: 2568139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]